SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2 Clinical Study in Patients with Stargardt Disease
SB-007 is the only IND-cleared, clinical-stage therapeutic addressing the root cause of Stargardt disease with the potential to treat all patients across all ABCA4 mutations Phase 1/2 ASTRA study set to begin in the first half of 2025, supported by POLARIS, a pioneering company-sponsored natural his
Neuraxpharm and Pharmathen enter into strategic co-development agreement to develop long-acting injectable therapies
New therapies will allow patients greater choice and flexibility in the control of CNS disorders BARCELONA, Spain, DÜSSELDORF, Germany, and ATHENS, Greece, Dec. 12, 2024 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatme
WuXi Biologics Included in UNGC 20 Case Examples of Sustainable Development for 20 Years Collection
Leading Green CRDMO Driven by Innovation for a Healthier Future Offering End-to-end Green Biologics Solutions for the Entire Industry SHANGHAI, Dec. 12, 2024 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Or
KIND Presents Preclinical Results of AND017 in Animal Models of Sickle Cell Disease (SCD), Myelodysplastic Syndromes (MDS), and β-Thalassemia at the 66th American Society of Hematology Meeting and Exposition and Announces FDA Authorization of Investigational New Drug (IND) Application for AND017 for Clinical Trial in Sickle Cell Disease (SCD)
SAN FRANCISCO, Dec. 12, 2024 /PRNewswire/ — Kind Pharmaceutical (“Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC”), a clinical-stage biopharmaceutical company focused on developing innovative medicines to treat hematological diseases and cancers, today announced t
Air France expands network with 3 weekly non-stop flight between Manila and Paris
MANILA, Philippines, Dec. 12, 2024 /PRNewswire/ — Air France has officially inaugurated a new 3 weekly non-stop flight between Manila and Paris on Sunday 8 December. In a pre-departure ribbon-cutting ceremony, Secretary of Transportation, Jaime J. Bautista, Secretary of Tourism, Christina Gar
China remains the main engine of global trade growth: Global Times editorial
BEIJING , Dec. 12, 2024 /PRNewswire/ — According to statistics recently released on the official website of the General Administration of Customs, the total value of China’s goods trade reached 39.79 trillion yuan ($5.6 trillion) in the January-November period, expanding by 4.9 percent
RSNA 2024 Spotlight: Careverse Leads the New Trend in Medical AI
CHICAGO, Dec. 12, 2024 /PRNewswire/ — From December 1st to 5th, 2024, RSNA 2024—the largest and most future-oriented top medical event in the global radiology community, was held in Chicago. At this conference, Careverse officially made its debut, exhibiting in the AI Showcase area, sharing
Hyundai Mobis to Showcase World’s First Full-Windshield Holographic Display at CES 2025
The groundbreaking display projects critical driving information across the entire width of the windshield, offering a panoramic and immersive experience that spans from the driver’s seat to the passenger’s seat. Hyundai Mobis will also present its suite of human-centric technologies at
Kerry Logistics Network Wins HKEJ Listed Company Awards of Excellence and IR Magazine Award
HONG KONG, Dec. 12, 2024 /PRNewswire/ — Kerry Logistics Network Limited (‘KLN’; Stock Code 0636.HK) was once again recognised for its exceptional business and investor relations (IR) performances over the past year, winning the Hong Kong Economic Journal Listed Company Awards of Ex
Dstny appoints Vladan Petrovic as Group Chief People Experience Officer
BRUSSELS, Dec. 12, 2024 /PRNewswire/ — Dstny, the Belgian technology company that has become a European innovator and developer of cloud-based business communication solutions, has appointed Vladan Petrovic as Chief People Experience Officer for the Dstny Group. Vladan brings over 20 years
